Send the following on WhatsApp
Continue to Chathttps://es.marketscreener.com/cotizacion/accion/APOLLOMICS-INC-152896960/noticia/Apollomics-Inc-Anuncia-la-eficacia-de-vebrelinib-en-pacientes-con-CPNM-con-mutaci-n-que-omite-la-M-45130578/?utm_source=whatsapp&utm_medium=social&utm_campaign=share